Atlas Trials

A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers

Clinical trial NCT05206370 · COMPLETED

Trial details

NCT number
NCT05206370
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2022-01-20
Primary completion
2023-03-21
Enrollment
792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.